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EDITORIAL REVIEW
Regulation of the Na,K-pump in skeletal muscle
The regulatory problem
Over the last 30 years it has been firmly established that the
active coupled transport of Na and K across the plasma
membrane is mediated by the Na,K-ATPase, and that this
enzyme plays a central role in the Na-K homeostasis of
virtually all animal cells [reviewed in 1 and 2].
More recently, it has become evident that both the activity
and the concentration of this transport system are subject to
regulation by a variety of hormonal and non-hormonal factors.
This is of particular significance in the skeletal muscles, mainly
because they contain the largest single pool of K as well as a
major part of the Na,K-pumps in the body.
The problem of K homeostasis and the prominent role of
skeletal muscle is perhaps best illustrated by the time course of
changes in plasma K during repeated bouts of maximum
exercise. As shown in Figure 1, the K concentration of arterial
blood increases by more than 3 mmol/liter within less than one
minute, followed by a complete reversal to the resting level
within around four minutes. These dramatic changes demon-
strate that during maximum activity the net loss of K from the
working muscles exceeds the capacity for reaccumulation via
the Na,K-pump, whereby the heart is exposed to a K concen-
tration of at least 7 mmol/liter. Conversely, even a short resting
period is sufficient to allow a complete clearing of the extra K
from plasma and the extracellular phase, illustrating the con-
siderable functional capacity of the Na,K-pump [3]. Other
studies have shown that during rest following the intense
exercise of playing squash, plasma K + may reach values
around 3.2 mmol/liter [4]. The fact that both extremes of plasma
K may cause cardiac arrest or interfere with contractile
performance underscores the severity of the regulatory prob-
lem. It is obvious, therefore, that close regulation is essential
for survival.
The long-term control of plasma K ultimately depends on
kidney function, but due to their large capacity for rapid
Na-K exchange the skeletal muscles play a dominant role in
the acute, from minute-to-minute ongoing adjustment of plasma
K [5, 6]. The regulation of Na,K-transport in skeletal muscle
has recently been reviewed in detail [7]. In the following
presentation, more fundamental aspects and their clinical im-
plications will be emphasized and the recent observations in
this rapidly developing field will be described.
Quantification of Na,K-leaks and Na,K-pumps in muscle
A quantitative analysis of the K leaking out of working
muscles must be based on measurements of the K efflux per
contraction taking place in isolated muscles. Isotopic flux
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studies indicate that the unidirectional effiux of K per contrac-
tion varies between 4 and 16 nmol/g wet wt depending on
temperature and preparation [8—10]. In rat soleus at 30°C, a
value of 9 nmol/g wet wt was found [9]. The same studies
showed that there was a concomitant Na influx of the same
order of magnitude [8—10].
It is reasonable to assume that the unidirectional effiux of K
from working muscles will increase as a linear function of the
frequency of contractions, and as shown in Figure 2, even
moderate contractile activity leads to a considerable K effiux.
It should be noted that the frequency of contractions reached
during a standard bicycle exercise experiment is around 25 per
second [11]. In the leg muscles of the rat, this frequency would
lead to a K effiux of (25 x 60 x 9) or around 13,500 nmol/g per
mm at 30°C, and even more at body temperature.
In order to get an idea about the potential of the muscles to
counterbalance this loss of K, the K influx via the Na,K-
pump should be quantified. As shown in Figure 2, this ouabain-
suppressible K influx amounts to only 250 nmol/g wet wt per
mm in the resting rat soleus muscle at 30°C.
Obviously, this is far from sufficient to restore the K lost
during work, and it is of considerable interest, therefore, to
estimate the total capacity of K accumulation via the Na,K-
pump. Complete quantification of the concentration of Na,K-
ATPase in muscle is difficult, mainly due to incomplete recov-
ery and the formation of inside-out vesicles of the sarcolemma
[12]. Measurements of 3H-ouabain binding to intact muscle
preparations or to muscle biopsies, however, have given highly
reproducible values for the total concentration of the Na,K-
ATPase [13].
Over a wide range of 3H-ouabain binding site concentrations
it could be shown that the 3H-ouabain binding assay quantifies
functional Na,K-pumps [14]. Furthermore, measurements of
the total Na,K-ATPase concentration [15, 16] and 3-0-methyl-
fluorescein phosphatase activity [17] in crude muscle homoge-
nates have given values in good agreement with determinations
of the total 3H-ouabain capacity of intact muscles.
The maximum capacities for K influx via the Na,K-pump in
the isolated soleus muscle of 4-week-old rats at 30 and 37°C are
indicated by dashed horizontal lines in Figure 2. It is evident
that the K loss during contractile activity may readily exceed
even these maximum levels, This may account for the fact that
during chronic electrical stimulation at 10 Hz in vivo, muscles
undergo an appreciable net loss of K and gain of Na4, which
is only recovered following a period of rest [18, 19]. This may be
of importance for the pain and the development of degenerative
changes associated with prolonged tonic muscle contractions.
In man, the concentration of 3H-ouabain binding sites in
skeletal muscle is around 280 pmollg wet wt [20—22], corre-
sponding to a theoretical maximum K accumulation rate of
4,480 nmol/g wet wt/min at 37°C.
In conclusion, the concentration of Na,K-pumps in skeletal
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muscle can be quantified using biopsy specimens of around 5 to
20 mg and a relatively simple 3H-ouabain binding assay [23, 24].
A comparison of the Na,K-pump concentration with the values
for K efflux per contraction shows that during contractile
activity, the loss of K and the gain of Na via passive leaks
often exceed the maximum capacity of the available Na,K-
pumps for restoring the Na,K-gradients across the muscle cell
membrane [9].
Acute regulation
The immediate, from minute to minute ongoing control of
active Na K transport mainly seems to be exerted by
activation of the Na,K-pump. Inhibitory factors have been
detected in plasma, but at present their significance for acute
regulation is not clarified [25]. The major physiological stimuli
for the Na,K-pump are excitation, catecholamines and insulin.
Excitation
In single frog muscle fibers stimulated at a frequency of 1.5
Hz, only a 10% rise in intracellular Na (Na1) was observed
[10]. Surprisingly this was associated with a concomitant stim-
ulation of 24Na efflux of 109%, indicating that the Na,K-pump
may be activated over and above what can be predicted by the
relative rise in Na1. The observation is even more remarkable
when taking into account that the entry of unlabelled Na
during excitation would be expected to cause dilution of the
specific activity of the intracellular 24Na with ensuing reduction
of the fractional loss of 24Na. The model for K efliux and
Na,K-pump activation during exercise developed by Hazeyama
and Sparks [26] predicts that the Na,K-pump is activated by
around 65% within the first three minutes of stimulation at a
frequency of 4 Hz. According to their calculations, the rise in
Na1 is not larger than 15% within this period. Recent experi-
ments with isolated rat soleus muscle have shown that electrical
stimulation at a frequency of 2 Hz is associated with a 74%
increase in ouabain-suppressible 22Na efflux [27] and a 110%
increase in ouabain-suppressible 86Rb uptake (Fig. 3). These
values were obtained within a 10 minute period of stimulation
and were accompanied by an increase in Na1 of 15% (as
determined after the 10 mm stimulation period).
Comparison of the effects of electrical stimulation at 2 Hz on
the ouabain-suppressible 86Rb uptake in rat soleus (slow-twitch)
and extensor digitorum longus (EDL) (fast-twitch) muscle dem-
onstrated that the stimulation of the Na,K-pump during excita-
tion was more than three times larger in soleus than in EDL
[27]. A similar difference between the two muscles has been
observed when the Na,K-pump is stimulated with catechol-
amines [27—29].
It has been calculated that stimulation at a frequency of 15 Hz
would result in a 60% increase in Na1 in skeletal muscle which
would result in a similar relative increase in Na,K-pump rate
[30]. Measurements with Na-sensitive electrodes have shown
that the intracellular Na activity in mouse soleus muscle may
increase by around 80% within one minute of application of
stimulus trains at a frequency of 40 Hz [31]. On the basis of the
recovery of intracellular Na activity after stimulation [311 it
could be calculated that the Na,K-pump was stimulated to
around 10 times the resting activity [7], corresponding to 40% of
its theoretical maximum rate. The discrepancy between the
relative rise in intracellular Na activity and Na,K-pump acti-
vation was even larger when the activation of the Na,K-pump
during recovery was calculated on the basis of the recovery of
K1, that is, for an 80% increase in intracellular Na activity a
20-fold stimulation of K + influx could be calculated [31]. This is
surprising in view of the observation that in resting skeletal
muscle, the Na,K-pump mediated K influx increases as a
linear function of Na1 and that a rise in Na1 of 80% caused an
increase of only 67% in Na,K-pump mediated K influx [32].
Since the plasma catecholamine level rises considerably
during intense exercise [33], partly due to norepinephrine
release from sympathetic nerve endings in the muscles [34], the
activation of the Na,K-pump induced by excitation might
depend on a local action of norepinephrine. However, recent
experiments with isolated rat soleus muscle have shown that
the excitation-induced stimulation of 22Na efflux could not be
prevented by propranolol [27]. The same study showed that the
effects of epinephrine and excitation were not additive in either
soleus or EDL muscle, indicating that they may activate the
Na,K-pump through the same mechanism.
At present it is only possible to speculate about the functional
significance of an excitation-induced activation of the Na,K-
pump. Recently, it has been proposed that development of
fatigue might be partly explained by inexcitability due to
accumulation of K ions in the extracellular space [35, 36]. This
suggests that resistance to fatigue might be partly ascribed to
the capacity of the Na,K-pump to clear K from the extracel-
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Fig. 1. Changes in the K concentration of
arterial blood plasma in trained human
subjects during repeated bouts of maximum
exercise each lasting from 30 to 60 seconds
(reproduced with permission from ref. 3).
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Fig. 2. Comparison of K loss induced by contractile activity and
K influx via the Na K-pump. In isotope flux studies at 30°C, a
unidirectional K efflux of 9 nmol/g wet wt per contraction was
estimated for soleus muscle of 4 week-old rats [9]. On the basis of
this value, the K efflux was calculated at varying frequencies of
contraction. For comparison, the ouabain-suppressible component
of K influx is indicated for resting [7] and for Na-loaded rat
soleus muscle at 30°C (data from ref. 14). The theoretical
maximum ouabain-suppressible K influx at 37°C has been
calculated on the basis of the 3H-ouabain binding site
concentration and the turnover number of the Na,K-pumps at
40 this temperature (0.7 x 8,000 x 2 = 11,200 nmol K per g wet wt
per mm).
lular space. This is, in particular, important in slow-twitch
muscles like rat soleus, which have a rather high level of
activity during the day [37]. In addition, the finding that the
excitation-induced stimulation of the Na,K-pump was threefold
larger in soleus than in EDL muscle, might be related to the fact
that slow-twitch muscles have a much higher resistance to
fatigue than fast-twitch muscles [38].
Catecholamines
A wide variety of experiments carried out over the last 50
years have shown that catecholamines stimulate the uptake of
K and increase the K content in skeletal muscle. The
injection of epinephrine was found to increase the arteriove-
nous difference for K in the hindlimbs of dogs and frogs [39,
40] as well as in the human forearm [41—43]. In the perfused dog
gracilis muscle, epinephrine induced an increased net K
uptake within three minutes [44], and in cats, an increase in the
K content of skeletal muscle [45].
In vitro studies have shown that both epinephrine and nor-
epinephrine increase K content as well as the intracellular
concentration of K in rat soleus [28, 46, 47] and EDL muscle
[28, 48]. Isotopic flux measurements using 42K or 86Rb as
tracers for K have demonstrated that both epinephrine and
norepinephrine stimulate the ouabain-suppressible component
of K influx quite markedly in rat and guinea pig soleus [28, 46,
47, 49—51]. As can be seen from Figure 3, this effect is more
pronounced and rapid in onset than that induced by insulin, but
almost as large as that elicited by electrical stimulation at a
frequency of 2 Hz. Considerably smaller stimulation was ob-
tained in rat EDL muscle, suggesting that in fast-twitch fibers
the Na,K-pump responds less than in slow-twitch fibers [27,
28].
Epinephrine was shown to stimulate 22Na efliux in frog
sartorius [52, 53], mouse diaphragm [54] and rat soleus [46, 47,
51, 55]. Again, this effect was more pronounced in soleus than
in EDL [28]. The fact that both the effects on K influx and Na
efflux could be suppressed by ouabain indicate that they are the
result of activation of the Na,K-pump. It should be emphasized
that this could not be accounted for by increased Na1 or by a
decrease in K content. Indeed, several studies have shown
that epinephrine (as well as other /32-adrenoceptor agonists)
induces a decrease in Na1 which in rat soleus may reach values
as low as one third of the control level [46, 47, 52, 56]. As shown
for 22Na efflux this effect was larger in soleus than in EDL
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Fig. 3. Comparison of the effects of insulin, epinephrine and electrical
imulation on ouabain-suppressible 86Rb influx in isolated rat soleus
muscle. Intact muscles were prepared from 4 week-old rats and
incubated in Krebs-Ringer bicarbonate buffer at 30°C. After preincuba-
tion for 15 mm without or with ouabain (1 mM), the muscles were
incubated for 5 to 10 mm in buffer containing 86Rb (0.1 sCi/ml) without
or with ouabain (1 mM). Where indicated the radioactive buffer con-
tained insulin (100 mU/mi) or epinephrine (10 LM). Part of the muscles
was exposed to direct electrical stimulation of 2 Hz using 10 V pulses of
1 msec duration. On the basis of the specific activity of the incubation
medium, the amount of 86Rb taken up was calculated and expressed as
nmol/g wet wt. The ouabain-suppressible 86Rb uptake was taken as the
difference of the values obtained in the absence and in the presence of
ouabain. Symbols are: (x) rest, (i) + adrenaline (10 SM), (0) + insulin
(100 mU/mi); and (•) electrical stimulation (2 Hz).
muscles [57]. Once this lower steady-state level for Na1 has
been established, the rate of 22Na efflux may be considerably
smaller than that of the control muscles [55]. In the Purkinje
fibers of the dog heart, both isoproterenol and norepinephrine
induce a decrease in intracellular Na activity which can be
blocked by propranolol or strophanthidin [58, 591. Recent
studies with isolated rabbit cardiac myocytes indicate that this
effect is not due to changes in extracellular K [60]. Direct
recordings with ion sensitive microelectrodes demonstrated
that in human intercostal muscle fibers as well as in rat soleus
muscle, epinephrine induces a decrease in the intracellular Na
activity, hyperpolarization and an increase in intracellular K
activity [61]. All these effects could be blocked by ouabain,
indicating that they were secondary to stimulation of the
Na,K-pump.
The stimulating effect of catecholamines on active Na,K-
transport can be observed at physiological concentrations, and
is mediated via /32-adrenoceptors and activation of the adenyl-
ate cyclase [46, 49, 56]. This effect accounts for the hyperpo-
larizing action of catecholamines in muscle [46, 62—65].
The observation that catecholamines increase the rate of
3H-ouabain binding is a specific indication that the Na,K-
ATPase is activated [66], but there is no direct evidence that
catecholamines can activate Na,K-ATPase prepared from skel-
etal muscle. Thus, the addition of cAMP caused no change in
enzyme activity [67]. In kidney tubule cells, however, pretreat-
ment with norepinephrine caused an increase in the activity of
Na,K-ATPase subsequently prepared from the tissue [68].
In conclusion, catecholamines induce marked and rapid
activation of the Na,K-pump in skeletal muscle, favoring net
intracellular accumulation of K. This is important for the
reduction of plasma K during exercise. Furthermore, /32-
adrenoceptor agonists may be used to suppress hyperkalemic
attacks [49, 69—71] as well as hyperkalemia in renal insufficiency
[72]. The fatigue associated with treatment with /3-blockers may
be related to the hyperkalemia caused by suppression of the
catecholamine activation of the Na,K-pump [73, 74]. It has
been proposed that some cases of sudden death occurring after
severe exercise are related to catecholamine-induced hypoka-
lemia [4].
Insulin
The hypokalemic effect of insulin is the result of increased net
uptake of K in muscle cells which is separate from the effect
on glucose transport [51, 75]. Thus, physiological concentra-
tions of the hormone augment the arteriovenous difference for
K in the human forearm [76], and several in vitro studies have
shown that insulin induces a net increase in the K content in
muscle [77—82]. The intracellular K concentration is increased
by around 10% [47, 78, 82, 83], and in cultured chicken heart
cells, this effect is blocked by ouabain [84]. One study demon-
strated an increase in the intracellular K activity [85], whereas
others were unable to detect any change in the intracellular
concentration [81, 86] or activity of K [87].
Insulin increases the influx of 42K, 86Rb or '34Cs in isolated
muscle preparations [47, 79, 82, 88—91], and in the rat soleus,
insulin was found to increase the rate of 3H-ouabain binding, a
specific indication that the turnover of the Na,K-pump is
augmented. The effects on isotope uptake were blocked by
ouabain [47, 82, 88, 89, 91], indicating that the effect of insulin
is mediated through the Na,K-pump [66].
As can be seen from Figure 3, the effect of a maximum
stimulatory concentration of insulin on ouabain-suppressible
86Rb-influx is somewhat smaller and slower in onset than that of
epinephrine or electrical stimulation.
Insulin was shown to increase Na efflux by between 25 and
70% [47, 55, 82, 83, 88, 92—94]. This effect could be blocked by
cardiac glycosides or K-free buffer in frog muscle [88, 92], but
not in rat soleus [82]. The effect of insulin on the Na,K-pump
may account for the hyperpolarizing action of the hormone [47,
51].
Since insulin in intact muscle preparations induces a decrease
in the intracellular concentration of Na [78, 81, 83, 95] which
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can be blocked by ouabain [47, 82, 92, 96], it is unlikely that the
effects on Na K transport are the result of the Na,K-pump
being activated by increased availability of Na in the cyto-
plasm. In cultured myocytes, however, insulin was recently
reported to stimulate Na,K-pump activity through a rise in
intracellular Na resulting from an increased passive Na
influx via the Na/H exchange system [97].
Several attempts have been made to detect an effect of insulin
on the activity of the Na,K-ATPase in muscle, but only one
laboratory [67] has reported that the enzyme can be stimulated
by the direct addition of insulin to a muscle membrane prepa-
ration [98].
The effects of insulin and epinephrine on K accumulation
and Na efflux are additive, indicating separate mechanisms of
action [47]. This is of particular importance since the insulin-
induced hypoglycemia may induce stimulation of catechol-
amine secretion, and the simultaneous elevation of the plasma
levels of both hormones was indeed shown to produce a larger
decrease in plasma K than either hormone alone [99]. The role
of insulin in K homeostasis has been documented by the
demonstration of insulin secretion being stimulated by hyper-
kalemia [100, 101]. Whereas moderate hyperkalemia seems to
be counterbalanced by insulin-induced stimulation of hepatic
K uptake, more pronounced elevations of plasma K are
associated with increased insulin levels in the peripheral blood
and augmented K uptake in skeletal muscle [6].
In conclusion, insulin induces activation of the Na,K-pump in
skeletal muscle at physiological concentrations. This can ac-
count for the increase in intracellular K/Na ratio, the hyper-
polarization as well as a major part of the hypokalemic action.
There is a negative feedback relationship between plasma K
and insulin secretion, whereby the hormone contributes to
plasma K homeostasis.
Other factors
Studies with metabolic inhibitors have shown that in rat
soleus muscle, the Na,K-pump mediated Na efflux and K
influx are suppressed [14, 82]. This is likely to reflect the
requirement for ATP as an energy supply for the Na,K-pump.
For the same reason, anoxia leads to inhibition of active
NaK transport with ensuing loss of intracellular K and a
rise in interstitial Kt Since the ATP concentration required to
produce half maximum saturation of the Na,K-ATPase is rather
low (1 mM), cellular ATP has to undergo an appreciable
reduction before severe interference with active NaK trans-
port is seen.
Vanadate (V04) is a potent inhibitor of Na,K-ATPase (as well
as a number of other ATPases). Since muscle cells contain
vanadate, this compound has been proposed as a potential
regulator of the Na,K-pump, but as yet there is little support for
this concept.
Long-term regulation
The long-term regulation of the Na,K-pump in skeletal mus-
cle is achieved by variations in its concentration. These varia-
tions may occur as a physiological consequence of development
and differentiation or training, or may be seen under patholog-
ical circumstances as hypo- and hyperthyroidism, uncontrolled
diabetes, starvation, immobilization, K deficiency and chronic
renal failure. The mechanism of induction of the changes in
Na,K-pump concentration is not necessarily identical under the
various circumstances and will be discussed in the following
paragraphs.
Thyroid hormones
It has been known for around 15 years that the Na,K-ATPase
activity in skeletal muscle increases as function of the thyroid
status [102—104]. This increased activity of the Na,K-pump was
also suggested to account for the major part of the calorigenic
action of thyroid hormones [102, 103]. However, measurements
of the ouabain-suppressible heat production have shown that
active Na,K-transport in intact skeletal muscle only accounts
for a minor part (5%) of the total heat production [105], which
fraction only increases modestly with the thyroid status [106].
Measurements of the 3H-ouabain binding site concentration
in intact mouse soleus muscles [106] or in strips and biopsies
from rat soleus muscle [23, 107] indicate that in hyperthyroid
animals, the entire population of Na,K-ATPase molecules in
the muscles may be up to 10-fold larger than in hypothyroid
animals (Fig. 4). Biopsies of human vastus lateralis muscles
showed that the concentration of 3H-ouabain binding sites
varied over a sixfold range with the free T4-index [20]. Further-
more, it was shown that these changes were fully reversible
when the thyroid status was normalized by standard therapy
[20].
Since skeletal muscles vary considerably with respect to their
contractile, metabolic and fatigue properties [38, 108—110], the
effects of thyroid hormones on Na,K-ATPase activity have
been examined in muscles containing varying proportions of
slow- and fast-twitch fibers. This demonstrated that the effect
was present in soleus and diaphragm (mainly slow-twitch and
red) as well as in EDL and gastrocnemius (mainly fast-twitch
and white) muscle [107], but it was more pronounced in muscles
with a large proportion of slow-twitch or red fibers in young and
in adult rats (Fig. 4). The same study also showed that the
thyroid hormone-induced changes in 3H-ouabain binding site
concentration could not be accounted for by differences in
affinity or the rate of 3H-ouabain binding [107]. The implication
of these results is that the effect of thyroid status on the
Na,K-pump concentration is present throughout the skeletal
muscle pool and might be one of the major factors explaining
the common clinical experience that digitalis glycoside toler-
ance increases with thyroid status [111, 112].
Recently, it has been demonstrated that the large increase in
3H-ouabain binding site concentration in hyperthyroidism is
associated with a proportional increase in the maximum rate of
ouabain-suppressible 86Rb uptake [14]. The latter was, how-
ever, measured in Na-loaded muscles exposed to high extra-
cellular K, which is not a common physiological situation.
With normal Na and extracellular K an increase in basal
ouabain-suppressible 42K or 86Rb uptake is found in hyperthy-
roid soleus and EDL muscles [29, 106] which was of the same
order of magnitude as the respective increases in Na,K-pump
concentration. Nevertheless, the total Na and K contents in
skeletal muscles are unchanged with hypo- and hyperthyroid-
ism [106, 107, 113]. This suggests that the increased influx of
K and efflux of Na in hyperthyroidism is counter-balanced
by an increased efflux of K and influx of Nat.
It has indeed been demonstrated that thyroid hormone in-
creases the passive permeability of Na and K in skeletal
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Fig. 4. Effect of thyroid status on the concentration of 3H-ouabain
binding sites (Na,K-pumps) in various skeletal muscles of the rat.
Muscle specimens were prepared from 12 week old hypo-, eu- or
hyperthyroid rats and the concentration of 3H-ouabain binding sites was
determined using the vanadate facilitated binding assay [23] (repro-
duced with permission from ref. 107). Symbols are: (x) soleus; (0)
diaphragm; (S) EDL: () gastrocnemius.
muscle [114, 115]. More recently, it was shown for both rat
liver, kidney tubules and skeletal muscle that the passive efflux
of K was increased after thyroid hormone treatment before
any increase in Na,K-ATPase activity could be detected [116—
1181. The time course of increase in Na uptake was similar to
that of the rise in K efflux [118]. These observations lend
further support to the idea that the increase in Na,K-ATPase
activity after thyroid hormone treatment represents a specific
response to the leak of K from or influx of Na into the
muscles, The finding that the early phase of the thyroid hor-
mone-induced increase in Na uptake (12 to 24 hrs) could be
suppressed by amiloride suggests that part of the increase in
Na uptake is due to stimulation of the Na/H exchange,
which in turn is stimulated by a rise in cytosolic Ca concen-
tration [118].
The interesting point of course is that each action potential is
associated with influx of Na and effiux of K, which will
account for the major part of the passive Na,K-leaks in skeletal
muscle (Fig. 2). It remains to be established to which extent
possible changes in Na,K-fluxes and Na,K-pump activity dur-
ing work may account for the fatigue and weakness commonly
observed in hypo- and hyperthyroid patients [119].
In conclusion, the concentration of Na,K-pumps in skeletal
muscle is to a major extent controlled by thyroid hormones.
The thyroid hormone-induced increase in Na,K-pump concen-
tration seems to represent an adaptation to increased passive
leaks of Na and K. The rise in Na,K-ATPase concentration
with thyroid status is observed throughout the skeletal muscle
pool and is probably the major factor determining the increased
digitalis glycoside tolerance seen with increasing thyroid hor-
mone levels. Furthermore, it could be of importance for the
hypokalemic attacks seen among certain hyperthyroid subjects
[120].
The effect of thyroid hormone on the synthesis of Na,K-
pumps is of considerable general significance in view of the fact
that decreased serum T3 is seen in a variety of diseases as well
as during caloric restriction [121]. As exemplified below, this is
associated with a reduction in the concentration of Na,K-
pumps.
Diabetes and starvation
As insulin increases the rate of active Na,K-transport
acutely, the question may arise whether the low plasma insulin
level in diabetes will result in a reduction of the transport rate.
Furthermore, if this is the case, the question will be whether
this is due to a reduction of the molecular activity of the
Na,K-ATPase or a downregulation of the enzyme concentra-
tion.
In streptozotocin-diabetic rats the soleus muscle showed a
48% increase in intracellular Na content, without any change
in intracellular K content [122]. Recent measurements of
3H-ouabain binding site concentration in soleus muscle biopsies
have shown that streptozotocin-induced diabetes in rats is
associated with a considerable (48%) decrease in Na,K-pump
concentration without affecting the affinity of the Na,K-pump
for ouabain [123], In gastrocnemius muscle, a 38% decrease in
3H-ouabain binding site concentration was found which was
accompanied by a 33% increase in total Na and no change in
total K content [123]. The same study also showed that the
changes in Na,K-pump concentration and Na content were
completely prevented by insulin treatment.
Like the effect of thyroid hormones, the effect of diabetes on
Na,K-ATPase concentration was seen in muscles containing
various proportions of slow- and fast-twitch fibers, but it was
most pronounced in the slow-twitch muscles [1231. In untreated
insulin-dependent diabetic patients a 28% decrease in free T3
has been demonstrated [124]. Since thyroid hormone is one of
the major regulators of the Na,K-pump concentration in skele-
tal muscle, a reduction of the T3 level might clearly play a role
in the diabetes-induced decrease in Na,K-pump concentration.
However, hypothyroidism in adult mice or rats is not associated
with an increase in Na content [106, 1071, nor with a decrease
in muscle weight. This implies that in uncontrolled diabetes one
or more additional mechanisms are involved. It has been shown
that protein synthesis in gastrocnemius muscle of streptozo-
tocin-diabetic rats was only 30% of that in control rats [125],
which might account for the decrease in muscle weight [123].
The observation that the Na content was increased without a
concomitant decrease in K content might be related to dehy-
dration.
Starvation is accompanied by a decrease in the plasma levels
of thyroid hormones both in man [126] and the rat [127, 128].
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The Na,K-ATPase activity in sarcolemma isolated from rat
muscle has been shown to decrease by 50% after five days of
complete fasting [1291. However, measurements of the total
3H-ouabain binding capacity in intact muscle samples only
showed a decrease of 25% [128]. Semi-starvation, induced by
maintaining rats on one-third to one-half of their normal energy
intake for three weeks, was associated with a 50% reduction of
T3 and T4 levels, a 25% reduction in 3H-ouabain binding site
concentration in soleus muscle and only minor changes in total
Na and K content [1281. Also in semi-starvation, the reduc-
tion of Na,K-pump concentration is seen throughout the skel-
etal muscle pool and is fully reversible after refeeding [128).
In conclusion, both uncontrolled diabetes and semi-starva-
tion result in a down-regulation of the Na,K-ATPase concen-
tration in skeletal muscle. The two disorders have in common
that they are associated with a reduction of the T3 level, which
may, at least partly, account for the observed effects.
Age and development
Growth and differentiation of muscle cells is associated with
a marked increase in the concentration of Na,K-pumps, both in
the intact organism [130—132] and in cultures [133].
In rats and mice, the concentration of 3H-ouabain binding
sites increases three- to fivefold from birth to the fourth week of
age. This rise is followed by a progressive decrease, paripassu
with the increase in cell volume. In guinea pigs, which show
earlier development, maximum concentration of 3H-ouabain
binding sites is seen at birth, followed by a drop [131, 1321.
Studies in human subjects show no change in 3H-ouabain
binding site concentration in skeletal muscle from 18 to 80 years
of age [211.
Little is known about what drives the synthesis of Na,K-
pumps during development and differentiation, but at least
three factors could be of importance: 1) the plasma levels of
thyroid hormones increase over the first weeks of life [1341; 2)
over the same interval of time, intracellular Na undergoes a
decrease from 30 to 8 mrvi [135]; and 3) muscle activity is
increasing.
In conclusion, the early increase in Na,K-pump concentra-
tion seems to be part of the general development and differen-
tiation. Since this rise is likely to favor the clearance of K from
the extracellular phase, it may contribute to the improvement of
contractile performance observed in growing rats [136].
Training and inactivity
The exercise induced by hyperkalemia is reduced by training,
both in man [137] and in the dog [138]. This could be due to an
increased concentration of Na,K-pumps in skeletal muscle, and
indeed, six weeks of training was found to augment the activity
of Na,K-ATPase by 165% in the sarcolemma of dog gracilis
muscle [138]. The ouabain-suppressible component of resting
membrane potential in intercostal muscle fibers was also in-
creased, indicating that the electrogenic effect of the Na,K-
pump had become more pronounced. Measurements of the total
concentration of 3H-ouabain binding sites showed that follow-
ing three to six weeks of swim training there was an increase of
43 to 46% in the soleus and the EDL (Fig. 5), and 22 to 25% in
the spine muscles and the gastrocnemius. In contrast, the
diaphragm showed no increase, all indicating that the effects
were not exerted by a generally acting endocrine factor. This
upregulation was completely reversible after three weeks of
detraining [139]. In keeping with these observations, it was
found that inactivity induced by denervation, tenotomy or
plaster immobilization caused a reduction in the concentration
of 3H-ouabain binding sites [140—142]. The decrease in 3H-
ouabain binding site concentration with denervation was more
pronounced in rat soleus than in EDL, and whereas plaster
immobilization gave no change in EDL, the soleus showed a
33% decrease [143]. Conversely, denervation was reported to
increase the concentration of Na,K-ATPase or 3H-ouabain
binding sites in membrane fractions by between 20 and 200%
[144—146]. This discrepancy might be related to difficulties in
ensuring representative recovery of Na,K-ATPase activity dur-
ing the preparation of membrane fractions from skeletal muscle
[discussed in 12].
In conclusion, muscle activity is associated with a reversible
increase in the concentration of Na,K-pumps which could be
part of the basis for the improved K clearance during exercise
in trained subjects. The observation that training increases the
capacity to secrete epinephrine [147] suggests that increased
stimulation of the Na,K-pump by circulating catecholamines
contributes to the effect of training on K clearance.
K-deficiency
Potassium deficiency is a frequently occurring complication
to a large variety of diseases as well as to diuretic treatment. It
is associated with a selective loss of K from skeletal muscle
[148—150], smooth muscle [151], and to a minor extent heart
muscle [150].
Studies with cultured muscle cells as well as a variety of other
cell types have shown that K loss is associated with an
increase in the intracellular Na concentration and a progres-
sive rise in the concentration of Na,K-ATPase in the plasma
membrane [152—154]. This upregulation of Na,K-pumps is seen
as a general response to a demand for increased transport
capacity, allowing the clearance of Na* from the cytoplasm.
Indeed, erythrocytes prepared from K deficient animals or
human subjects have been shown to contain an elevated level of
Na,K-pumps and this is associated with virtually normal Na,K-
content [155, 156].
In contrast, in intact skeletal muscles in vivo, K deficiency
leads to a progressive and marked (up to 78%) loss of the
Na,K-pumps [149, 150, 157]. This unexpected response is seen
in a variety of species [reviewed in 1581, as well as in human
subjects suffering from K deficiency induced by chronic
diuretic treatment [22]. A possible explanation for the discrep-
ancy between the responses to K deficiency obtained in
isolated cells or tissues and in vivo is that K deficiency in the
intact animal or man primarily involves the regulation of plasma
K, whereas in isolated cells only the tissue K4 content is
subject to regulation. In the intact organism, therefore, other
control mechanisms are overriding the strictly cellular regula-
tion of Na,K-pump synthesis. This seems less surpising,
perhaps, when considering that an upregulation of the Na,K-
pump concentration is likely to favor the development of
hypokalemia and ensuing paralysis.
The downregulation induced by K deficiency was first
detected by determination of the 3H-ouabain binding site con-
centration [149], but has later been confirmed in measurements
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rat muscle can already be detected following three days of K
depletion, and full recovery is not achieved until after six days
of K repletion (Fig. 6), even though the K content of the
muscle cells was already normalized within a few hours [1501.
There is a close correlation between the reduction in muscle K
content and the concentration of Na,K-pumps, and down-
regulation of the Na,K-pumps can be induced by K deficient
fodder as well as diuretics or mineralocorticoid treatment [150,
159]. The decrease in 3H-ouabain binding site concentration
induced by magnesium depletion seems to be accounted for by
the concomitant reduction in K content [1601.
The downregulation is not initiated by a decrease in plasma
thyroid hormone levels, nor is there any resistance to the action
of thyroid hormone on the synthesis of Na,K-pumps [107].
Pronounced protein deficiency only gave modest reduction in
the concentration of 3H-ouabain binding sites in muscle, indi-
cating that the effect of K deficiency is not the result of a
general reduction in protein synthesis [150]. The effect of K
deficiency is unimpaired by denervation, indicating that it is not
mediated by the peripheral nerves [142]. On the other hand,
immobilization by tenotomy, plaster or denervation induced
normalization of the K content of muscle within a few hours,
indicating that contractile activity is important in eliciting the
selective K loss from the skeletal muscles [1421.
After intravenous injection of 3H-digoxin, the activity in
plasma was higher in K-depleted rats than in controls [161].
More recently, it was shown that following the injection of a
single dose of 3H-ouabain, the acute rise in plasma 3H-activity
was 77% larger in K-deficient rats than in age-matched con-
trols [141]. These observations indicate that consistent with the
reduction in the skeletal muscle pool of digitalis receptors, less
digitalis is cleared and more remains in plasma. In this connec-
P 0.005 tion it is interesting that in patients receiving digoxin treatment,
40 p 0.01 the concentration of 3H-ouabain binding sites in biopsies of the
vastus lateralis muscle was not significantly different from that
of comparable untreated controls [221.
Potassium deficiency is also associated with a reduced capac-
ity to clear an oral load of K [162], possibly in part because the
pool of functional Na,K-pumps in skeletal muscle is reduced.
However, the role of renal adaptation to low K diet was not
evaluated and might have contributed to the impaired K
clearance [162]. Conversely, K loading by administration of
K-enriched fodder for 10 days was found to cause a consid-
erable improvement in the capacity to clear an intravenous load
of K in the rat [163]. This was associated with increased
microsomal Na,K-ATPase concentration and in vivo 86Rb
uptake in hind limb skeletal muscle, indicating that K loading
leads to upregulation of Na,K-pump concentration in muscle.
Others, however, failed to detect any effect of K loading on
3H-ouabain binding site concentration of soleus muscle [1501.
In conclusion, the concentration of Na,K-pumps in the
skeletal muscles of the intact organism is to a major extent
controlled by the availability of K. In particular, K defi-
ciency leads to a pronounced downregulation of the Na,K-
pump concentration which has implications for the capacity to
clear intravenous loads of digitalis glycosides or K. The
functional significance of this phenomenon remains to be ex-
plored, but it can be expected to reduce the tendency to develop
early severe hypokalemia and paralysis, thereby prolonging
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survival and increasing the chance to gain access to K
repleting nutrients.
Chronic renal failure
As discussed in the beginning of this review, the long-term
regulation of K homeostasis ultimately depends on kidney
function. Although patients with chronic renal failure can
generally maintain a fairly satisfactory water and electrolyte
status, due to the compensatory action of surviving nephrons,
the end stage of the disease is accompanied by water and Na
retention as well as hyperkalemia [1641. These disturbances
might have consequences for the Na and K content and
Na,K-pump function in the extrarenal tissues.
Na,K-pump function in chronic renal failure has recently
been reviewed by Deepak and Kahn [165], but as these authors
pointed out there is little information on the Na,K-pump
mediated ion transport in tissues other than the uremic eryth-
rocyte. However, we can try to make some speculations on the
basis of the available data on NaK contents and membrane
potential in uremic muscle cells, combined with the changes in
K homeostasis and endocrine status observed in patients with
chronic renal failure.
A typical feature of the uremic muscle cell is a significant
increase in intracellular water [1641 indicating inadequate vol-
ume regulation of the muscle cells. The same study also
reported a minor decrease in the intracellular K concentration
of the muscles. In addition, measurements of membrane poten-
tial and intracellular Na have shown that the membrane
potential is decreased in uremic muscles, which was associated
with a proportional increase in intracellular Na [1661.
The observations in muscles also suggests that Na,K-pump
activity is reduced in uremia, which might be due to a reduced
concentration of Na,K-pumps or an intrinsic inhibition of the
Na,K-pump by the uremic plasma. In sarcolemma fractions
isolated from the heart, a decrease in Na,K-ATPase activity has
indeed been reported [167, 168]. Although some studies have
indicated the presence of inhibitory factors in the uremic
plasma, this question has not been settled yet. The observations
that muscle membrane potential and intracellular Na and K
are not normalized until after 6 to 12 weeks of dialysis [166]
would rather suggest that the abnormalities in the uremic
muscle are of more sustained character.
At least two of the factors responsible for the long-term
regulation of the Na,K-pump concentration in muscle tissue
may be of importance for the changes occurring during chronic
renal failure. These include K depletion and thyroid status.
Similar to the effects of K deficiency in intact animals or man,
the K depletion in uremia might in itself cause a reduction of
the Na,K-pump concentration of the muscle tissue. Further-
more, it has been shown that plasma T3 is decreased in uremia
[169] resulting in "tissue hypothyroidism" [170] which also
would result in a reduced concentration of Na,K-pumps.
It is concluded that, although direct measurements of Na,K-
pump concentration in muscles of uremic patients are lacking,
the available data indicate that the Na,K-pump concentration
might be reduced. This could be secondary to a low T3 level and
perhaps in part to K depletion, but remains to be established.
Conclusions
The largest acute physiological rise in plasma K occurs
during exercise and is caused by the net release of K from the
working muscles. This K1 loss is restored by reaccumulation
into the muscle cells via Na,K-pump dependent transport.
Therefore, the pool of Na,K-pumps in skeletal muscle plays a
central role in K homeostasis and is subject to both acute and
long-term regulation.
Acute activation of the Na,K-pump can be induced within
minutes by excitation, catecholamines (a /3-adrenoceptor effect)
or insulin. This counterregulates the hyperkalemia induced by
exercise or the ingestion of K-Hch nutrients.
Long-term regulation is exerted by control of the concentra-
tion of Na,K-pumps. The major endocrine factor stimulating
the synthesis of Na,K-pumps is thyroid hormone, and in man
and animals the Na,K-pump concentration varies with thyroid
status over a 6- to 10-fold range. In diabetes or during starva-
tion, where plasma T3 is reduced, the concentration of Na,K-
pumps is decreased. The Na,K-pump concentration increases
markedly during early growth and differentiation of muscle cells
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and is upregulated in proportion to muscle activity. In contrast
to what is seen in cell cultures, K deficiency in the intact
organism leads to a progressive downregulation of Na,K-pump
concentration in muscle cells. The regulatory and clinical
implications of these extrarenal control mechanisms are pre-
sented and discussed.
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